Between two worlds: Liminality and late-stage cancer-directed therapy

Omega (United States)

Volumn 71, Issue 2, 2015, Pages 99-125

  Adorno, Gail ^a  

^a UNIVERSITY OF TEXAS AT ARLINGTON   (United States)

Author keywords

Cancer; Chemotherapy; End of life; Existential; Liminality

Indexed keywords

ADAPTIVE BEHAVIOR; ATTITUDE TO DEATH; EXISTENTIALISM; HUMAN; NEOPLASMS; PROGNOSIS; PSYCHOLOGY; SURVIVOR; TERMINAL CARE; TERMINALLY ILL PATIENT; UNCERTAINTY;

ADAPTATION, PSYCHOLOGICAL; ATTITUDE TO DEATH; EXISTENTIALISM; HUMANS; NEOPLASMS; PROGNOSIS; SURVIVORS; TERMINAL CARE; TERMINALLY ILL; UNCERTAINTY;

EID: 84939549859     PISSN: 00302228     EISSN: 15413764     Source Type: Journal    
DOI: 10.1177/0030222815570589     Document Type: Article

References (124)

1. Albraido-Lanza, A. F., & Revenson, T. A. (2006). Illness intrusion and psychological adjustment to rheumatic disease: A social identity framework. Arthritis & Rheumatism, 55(2), 224-232.
2. Alderson, P. (1998). The importance of theories in health care. British Medical Journal, 317, 1007-1010.
3. Anderson, M. (2007). Spiritual journey with the dying, liminality, and the nature of hope. Liturgy, 22(3), 41-47.
4. Andrykowski, M. A., Steffens, R. F., Bush, H. M., & Tucker, T. C. (2013). Reports of 'growth' in survivors of non-small cell lung cancer and healthy controls: What is the value-added by the cancer experience? Psycho-Oncology. Advance online publication. doi:10.1002/pon.3281
5. Aronowitz, R. (2010). Decision making and fear in the midst of life. The Lancet, 375(9724), 1430-1431. doi:10.1016/S0140-6736(10)60610-1
6. Arrington, M. I. (2008). Prostate cancer and the social construction of masculine sexual identity. International Journal of Men's Health, 7(3), 299-306.
7. Abboud, C., Berman, E., Cohen, A., Cortes, J., DeAngelo, D., Deininger, M.,. Salem, Z. (2013). The price of drugs for chronic myeloid leukemia (CML) is a reflection of the unsustainable prices of cancer drugs: From the perspective of a large group of CML experts. Blood, 121(22), 4439-4442. doi:10.1182/blood-2013-03-490003
8. Balducci, L. (2006). Management of cancer in the elderly. Oncology, 20(2), 135-143.
9. Bern-Klug, M. (2004). The ambiguous dying syndrome. Health & Social Work, 29(1), 55-65.
10. Blume, S. S. (1992). Insight and industry: The dynamics of technological change in medicine. Cambridge, MA: MIT Press.
11. Braga, S. (2011). Why do our patients get chemotherapy until the end of life? Annals of Oncology, 22(11), 2345-2348.
12. Breitbart, W., & Heller, K. S. (2003). Reframing hope: Meaning-centered care for patients near the end of life. Journal of Palliative Medicine, 6(6), 979-988.
13. Brown, P. (1995). Naming and framing: The social construction of diagnosis and illness. Journal of Health and Social Behavior, Extra Issue, 35, 34-52.
14. Burr, V. (2003). Social constructionism. (2nd ed.). Padstow: Routledge.
15. Byock, I. (2000). Completing the continuum of cancer care: Integrating life-prolongation and palliation. A Cancer Journal for Clinicians, 50(2), 123-132.
16. Callahan, D. (1993). The troubled dream of life. New York, NY: Simon & Schuster.
17. Callahan, D. (2000). Death and the research imperative. The New England Journal of Medicine, 342(9), 654-656.
18. Cassell, E. J. (1982). The nature of suffering and the goals of medicine. The New England Journal of Medicine, 306(11), 639-645.
19. Centers for Medicare & Medicaid Services (CMS). (2010). Medicare hospice benefits (CMS Product No. 02154). Baltimore, MD: CMS.
20. Charmaz, K. (1983). Loss of self: A fundamental form of suffering in the chronically ill. Sociology of Health and Illness, 5(2), 168-195.
21. Charmaz, K. (1995). The body, identity, and self: Adapting to impairment. The Sociological Quarterly, 36(4), 657-680.
22. Charmaz, K., & Belgrave, L. L. (2013). Modern symbolic interaction theory and health. In W. C. Cockerham (Ed.), Medical sociology on the move: New directions in theory (pp. 11-39). Dordrecht, Netherlands: Springer.
23. Chochinov, H. M., & Cann, B. J. (2005). Interventions to enhance the spiritual aspects of dying. Journal of Palliative Medicine, 8(Suppl. 1), S103-S115.
24. Chochinov, H. M., Hack, T., Hassard, T., Kristjanson, L. J., McClement, S., & Harlos, M. (2005). Dignity therapy: A novel psychotherapeutic intervention for patients near the end of life. Journal of Clinical Oncology, 23(24), 5520-5525. doi:10.1200/JCO.2005.08.391
25. Colla, C. H., Morden, N. E., Skinner, J. S., Hoverman, J. R., & Meara, E. (2012). Impact of payment reform on chemotherapy at the end of life. Journal of Oncology Practice, 8(3S), e6s-e13s.
26. Connor, S. R. (2010). Hospice and palliative care: The essential guide (2nd ed.). New York, NY: Routledge.
27. Conrad, P., & Barker, K. K. (2010). The social construction of illness: Key insights and policy implications. Journal of Health and Social Behavior, 51(S), S67-S79.
28. Courtenay, W. H. (2000). Constructions of masculinity and their influence on men's well-being: A theory of gender and health. Social Science & Medicine, 50(10), 1385-1401.
29. Daneault, S., Dion, D., Sicotte, C., Yelle, L., Mongeau, S. Lussier,. Paillé, P. (2010). Hope and noncurative chemotherapies: Which affects the other? Journal of Clinical Oncology, 28(13), 2310-2313. doi:10.1200/JCO.2009.26.8425
30. DelVecchio-Good, M. (2001). The biotechnical embrace. Culture, Medicine, and Psychiatry, 25(4), 395-410.
31. Delvecchio-Good, M. (2010). The medical imaginary and the biotechnical embrace: Subjective experiences of clinical scientists and patients. In B. J. Good, M. M. J. Fischer, S. S. Willen, & M. DelVecchio-Good (Eds.), A reader in medical anthropology: Theoretical trajectories, emergent realities (pp. 272-283). Hoboken, NJ: Wiley-Blackwell.
32. DelVecchio-Good, M., Good, B. J., Schaffer, C., & Lind, S. E. (1990). American oncology and the discourse on hope. Culture, Medicine, & Psychiatry, 14(1), 59-79.
33. Earle, C. C., Venditti, L. N., Neumann, P. J., Gelber, R. D., Weinstein, M. C., Potosky, A. L.,. Weeks, J. C. (2000). Who gets chemotherapy for metastatic lung cancer? Chest, 117(5), 1239-1246.
34. Earle, C. C., Neville, B. A., Landrum, M. B., Ayanian, J. Z., Block, S. D., & Weeks, J. C. (2004). Trends in the aggressiveness of cancer care near the end of life. Journal of Clinical Oncology, 22(2), 315-321. doi:10.1200/JCO.2004.08.136
35. Emanuel, E. J., Young-Xu, Y., Levinsky, N. G., Gazelle, G., Saynina, O., & Ash, A. S. (2003). Chemotherapy use among Medicare beneficiaries at the end of life. Annals of Internal Medicine, 138(8), 639-43.
36. Emanuel, L., Bennett, K., & Richardson, V. E. (2007). The dying role. Journal of Palliative Medicine, 10(1), 159-68.
37. Epstein, R. M., & Street, R. L., Jr. (2007). Patient-centered communication in cancer care: Promoting healing and reducing suffering (NIH Publication No. 07-6225). Bethesda, MD: National Cancer Institute.
38. Fitch, K., & Pyeson, B. (2010). Cancer patients receiving chemotherapy: Opportunities for better management. Milliman Client Report. Retrieved from http://publications.milliman.com/research/health-rr/pdfs/cancer-patients-receivingchemotherapy.pdf
39. Frankl, V. (1959/1984). Man's search for meaning. New York, NY: Washington Square Press.
40. Franks, A., & Meteyard, J. (2007). The transforming grace of in between spaces. The Journal of Pastoral Care & Counseling, 61(3), 215-222.
41. Fojo, T., & Parkinson, D. R. (2010). Biologically targeted cancer therapy and marginal benefits. Clinical Cancer Research, 16, 5972-5980. doi:10.1158/1078-0432.CCR-10-1277
42. Giorgi, F., & Bascioni, R. (2009). Another infusion of hope. Journal of Clinical Oncology, 27(10), 1722-1723. doi:10.1200/JCO.2008.20.7126
43. Gold, J. (1985). Cartesian dualism and the current crisis in medicine-A plea for a philosophical approach: Discussion paper. Journal of the Royal Society of Medicine, 78(8), 663-666.
44. Gottlieb, S. (2001). Chemotherapy may be overused at the end of life. British Medical Journal, 322(7297), 1267. doi:http://dx.doi.org/10.1136/bmj.322.7297.1267/a
45. Granek, L., Krzyzanowska, M. K., Tozer, R., & Mazzotta, P. (2013). Oncologists' strategies and barriers to effective communication about the end of life. Journal of Oncology Practice, 9(4), 129-135. doi:10.1200/JOP.2012.000800
46. Hallenbeck, J. L. (2003). Palliative care perspectives. New York, NY: Oxford University Press.
47. Hart, B., Sainsbury, P., & Short, S. (1998). Whose dying? A sociological critique of the 'good death'. Mortality, 3(1), 65-77.
48. Heidegger, M. (1927/2008). Being and time. New York, NY: Harper Perrenial.
49. Ho, T. H., Barbera, L., Saskin, R., Lu, H., Neville, B. A., & Earle, C. C. (2011). Trends in the aggressiveness of end of life cancer care in the universal healthcare system of Ontario. Journal of Clinical Oncology, 29(12), 1587-1591.
50. Hutchison, T. A. (Ed.). (2011). Whole person care: A new paradigm for the 21st century. New York, NY: Springer.
51. Jakobsson, E., Bergh, I., Gaston-Johansson, F., Stolt, C. M., & Ohlen, J. (2006). The turning point: Clinical identification of dying and reorientation of care. Journal of Palliative Medicine, 9(6), 1348-1358.
52. Jakobsson, E., Bergh, I., & Ohlen, J. (2007). The turning point: Identifying end-of-life care in everyday health care practice. Contemporary Nurse: Advances in Contemporary Palliative and Supportive Care, 27(1), 107-118.
53. Janoff-Bulman, R., & Frantz, C. M. (1997). The impact of trauma on meaning: From meaningless world to meaningful life. In M. Power & C. Brewin (Eds.), The transformation of meaning in psychological therapies: Integrating theory and practice (pp. 91-106). Sussex, England: Wiley & Sons.
54. Johnson, J. O., Sulmasy, D. P., & Nolan, M. T. (2007). Patients' experiences of being a burden on family in terminal illness. Journal of Hospice & Palliative Nursing, 9(5), 264-269. doi:10.1097/01.NJH.0000289656.91880.f2
55. Keam, B., Oh, D. Y., Lee, S. H., Kim, D. W., Kim, M. R., Im, S. A.,. Heo, D. S. (2008). Aggressiveness of cancer-care near the end-of-life in Korea. Japanese Journal of Clinical Oncology, 38(5), 381-386. doi:10.1093/jjco/hyn031
56. Kolodziej, M., Hoverman, J. R., Garey, J. S., Espirito, J., Sheth, S., Ginsburg, A.,. Patt, D. (2011). Benchmarks for value in cancer care: An analysis of a large commercial population. Journal of Oncology Practice, 7(5), 301-306. doi:10.1200/JOP.2011.000394
57. Koutrouli, N., Anagnostopoulos, F., & Potamianos, G. (2012). Posttraumatic stress disorder and posttraumatic growth in breast cancer patients: A systematic review. Women & Health, 52(5), 503-516. doi:10.1080/03630242.2012.679337
58. Kotarba, J. A., & Johnson, J. M. (2002). Postmodern existentialism. In J. A. Kotarba & J. M. Johnson (Eds.), Postmodern existential sociology: A sociology of everyday life (pp. 3-14). Lanham, MD: Altamira Press.
59. Kralik, D., Visentin, K., & van Loon, A. (2006). Transition: A literature review. Journal of Advanced Nursing, 55(3), 320-329.
60. Kübler-Ross, E. (1969). On death and dying. New York, NY: MacMillan.
61. Kübler-Ross, E. (1975). Death: The final stage of growth. Englewood Cliffs, NJ: Prentice-Hall.
62. Lawe, D. (2013). The problem of late referrals to hospice. The S. Florida Hospital News & Healthcare Report. Retrieved from http://southfloridahospitalnews.com/page/The-Problem-of-Late-Referrals-to-Hospice/569/1/
63. Little, M., Jordens, C., Paul, K., Montgomery, K., & Philipson, B. (1998). Liminality: A major category of the experience of cancer illness. Social Science & Medicine, 47(10), 1485-1494.
64. Livestrong Report Committee. (2010). Cancer stigma and silence around the world: A Livestrong report. Retrieved from http://assets-livestrongorg.s3.amazonaws.com/media/site-proxy/data/0dbc94849bfc877ce767f6d8bdd09aae93abc7c0.pdf
65. Lorenz, K. A., Shugarman, L. R., & Lynn, J. (2006). Health care policy issues in end-oflife care. Journal of Palliative Medicine, 9(3), 731-748.
66. Lunney, J. R., Lynn, J., Foley, D. J., Lipson, S., & Guralnik, J. (2003). Patterns of functional decline at the end of life. Journal of the American Medical Association, 289(18), 2387-2392.
67. Maddi, S. (1990). Prolonging life by heroic measures: A humanistic existential perspective. In P. T. Costa, Jr. & T. G. R. Vanden Bos (Eds.), Psychological aspects of serious illness: Chronic conditions, fatal diseases, and clinical care. Master lectures in psychology (pp. 155-184). Washington, DC: American Psychological Association.
68. Maines, D. (2000). The social construction of meaning. Contemporary Sociology, 29, 577584.
69. Marchione, M. (2010, June 28). Overtreatment at the end of life. The hospice foundation of America's hospice and caregiving blog. Retrieved from http://blog.hospicefoundation.org/2010-06-01-archive.html
70. Martoni, A. A., Tanneberger, S., & Mutri, V. (2007). Cancer chemotherapy near the end of life: The time has come to set guidelines for its appropriate use. Tumori, 93(5), 417-422.
71. Matsuyama, R., Reddy, S., & Smith, T. J. (2006). Why do patients choose chemotherapy near the end of life? A review of the perspective of those facing death from cancer. Journal of Clinical Oncology, 24(21), 3490-3496.
72. McCall, G. J., & Simmons, J. L. (1978). Identities and interactions: An examination of human associations in everyday life. New York, NY: Free Press.
73. McClement, S. E., & Woodgate, R. L. (1997). Care of the terminally ill cachectic patient: Interface between nursing and psychological anthropology. European Journal of Cancer Care, 6(4), 295-303.
74. McPherson, C. J., Wilson, K. G., & Murray, M. A. (2007). Feeling like a burden: Exploring the perspectives of patients at the end of life. Social Science & Medicine, 64, 417-427.
75. Mehta, N. (2011). Mind-body dualism: A critique from a health perspective. Mens Sana Monograph, 9(1), 202-209. doi:10.4103/0973-1229.77436
76. Monforte-Royo, C., Villavicencio-Chavez, C., Tomas-Sabado, J., Mahtani-Chugani, V., & Balaguer, A. (2012). What lies behind the wish to hasten death? A systematic review and meta-ethnography from the perspective of patients. PloS One, 7(5), e37117. Retrieved from http://www.plosone.org/article/fetchObject.action?uri=info%3Adoi%2F10.1371%2Fjournal.pone.0037117&representation=PDF
77. Murillo, J. R., & Koeller, J. (2006). Chemotherapy given near the end-of-life by community oncologists for advanced non-small cell lung cancer. The Oncologist, 11, 1095-1099.
78. Murphy, R. F., Scheer, J., Murphy, Y., & Mack, R. (1988). Physical disability and social liminality: A study in the rituals of adversity. Social Science & Medicine, 26(2), 235-242.
79. Murray, S. A., Kendall, M., Boyd, K., Worth, A., & Benton, T. F. (2004). Exploring the spiritual needs of people dying of lung cancer or heart failure: A prospective qualitative interview study of patients and their carers. Palliative Medicine, 18(1), 39-45.
80. Nappa, U., Lindqvist, O., Rasmussen, B. H., & Axelsson, B. (2011). Palliative chemotherapy during the last month of life. Annals of Oncology, 22(11), 2375-2380. doi:10.1093/annonc/mdq778
81. National Cancer Institute (NCI). (2012, May 5). Targeted cancer therapies. Retrieved from http://www.cancer.gov/cancertopics/factsheet/Therapy/targeted
82. Neimeyer, G. J. (Ed.). (1993). Constructivist assessment: A casebook. Newbury Park, CA: Sage.
83. Ning, Y., Shen, Q., Herrick, K., Mikkelsen, R., Anscher, M., Houlihan, R.,. Lapane, K. (2012). Abstract LB-339: Cause of death in cancer survivors. In: Proceedings of the 103rd Annual Meeting of the American Association for Cancer Research, 72(8) (Suppl. 1). doi:10.1158/1538-7445.AM2012-LB-339
84. Parker-Oliver, D. (2000). The social construction of the "dying role" and the hospice drama. Omega, 40(4), 493-512.
85. Parsons, T. (1972). Definitions of health and illness in the light of American values and social structure. In E. G. Jaco (Ed.), Patients, physicians, and illnesses (pp. 97-117). New York, NY: The Free Press.
86. Parsons, T. (1983). Illness and the role of the physician. In L. H. Mayhew (Ed.), Talcott Parsons on institutions and social evolution: Selected writings (pp. 145-156). Chicago, IL: University of Chicago Press.
87. Patterson, J. T. (1987). The dread disease: Cancer and modern American culture. Cambridge, MA: Harvard University Press.
88. Patton, M. Q. (2002). Qualitative research and evaluation methods. Thousand Oaks, CA: Sage.
89. Peinado, S. (2011, December 22). Managing uncertainty in cancer communication, CRN Cancer Communication Research Center blog. Retrieved from http://www.crn-ccrc.org/posts/2011/december/22/managing-uncertainty-in-cancercommunication.aspx
90. Saito, A. M., Landrum, M. B., Neville, B. A., Ayanian, J. A., & Earle, C. C. (2011). The effect on survival of continuing chemotherapy to near death. BMC Palliative Care, 10(14), Retrieved from http://www.biomedcentral.com/1472-684X/10/14
91. Sandelowski, M. (1999). Culture, conceptive technology, and nursing. International Journal of Nursing Studies, 36(1), 13-20.
92. Sawyers, C. (2004). Targeted cancer therapy. Nature, 432, 294-297. doi: 10.1038/nature03095
93. Schildmann, J., Ritter, P., Salloch, S., Uhl, W., & Vollman, J. (2013). 'O?ne also needs a bit of trust in the doctor. ': A qualitative interview study with pancreatic cancer patients about their perceptions and views on information and treatment decisionmaking. Annals of Oncology, 24(9), 2444-2449. doi:10.1093/annonc/mdt193
94. Schroepfer, T. A. (2007). Critical events in the dying process: The potential for physical and psychosocial suffering. Journal of Palliative Medicine, 10(1), 136-147.
95. Seymour, J. (2007, September 8). Windows on suffering: Sociological perspectives on end of life care. Plenary Address to Annual BSA Medical Sociology Group Conference, Liverpool. Retrieved from http://www.medicalsociologyonline.org/oldsite/archives/issue22/jseymour.html
96. Schapira, L. (2013). Managing uncertainty. In A. Surbone, M. Zwitter, M. Rajer & R. Stiefel (Eds.), New challenges in communication with cancer patients (pp. 27-37). New York, NY: Springer.
97. Soh, T. I., Yuen, Y., Teo, C., Lim, S., Chan, N., & Wong, A. (2011). Targeted therapy at the end of life in advanced cancer patients. Journal of Palliative Medicine, 15(9), 991-997. doi:10.1089/jpm.2012.0050
98. Sparkes, A. C., Pérez-Samaniego, V., & Smith, B. (2012). Social comparison processes, narrative mapping and their shaping of the cancer experience: A case study of an elite athlete. Health: An Interdisciplinary Journal for the Social Study of Health, Illness and Medicine, 16(5), 467-488.
99. Spira, J. L. (2000). Existential psychotherapy in palliative care. In H. M. Chochinov & W. Breitbart (Eds.), The handbook of psychiatry in palliative medicine (pp. 197-214). New York, NY: Oxford University Press.
100. Steinhauser, K. E. (2005). Measuring end-of-life care outcomes prospectively. Journal of Palliative Medicine, 8, S30-S41.
101. Steinhauser, K. E., Alexander, S. C., Byock, I. R., George, L. K., & Tulsky, J. A. (2009). Seriously ill patient's discussions of preparation and life completion: An intervention to assist with transition at end of life. Palliative and Supportive Care, 7(4), 392-404. doi:10.1017/S147895150999040X
102. Syme, C. A. (2011). Organizing transitions in palliative care: Outside/inside cancer systems (Doctoral dissertation). Retrieved from https://dspace.library.uvic.ca:8443/handle/1828/3398
103. Temel, J. S., Greer, J. A., Muzikansky, A., Gallagher, E. R., Admane, S., Jackson, V. A.,. Lynch, T. L. (2010). Early palliative care for patients with metastatic non-small-cell lung cancer. The New England Journal of Medicine, 363(8), 733-742.
104. Temel, J. S., McCannon, J., Greer, J. A., Jackson, V. A., Ostler, P., Pirl, W. F.,. Billings, J. A. (2008). Aggressiveness of care in a prospective cohort of patients with advanced NSCLC. Cancer, 113(4), 826-833. doi:10.1002/cncr.23620
105. Teno, J. M., Weitzen, S., Fennel, M. L., & Mor, V. (2001). Dying trajectory in the last year of life: Does cancer trajectory fit other diseases? Journal of Palliative Medicine, 4(4), 457-464.
106. Teno, J. M., Gozalo, P. L., Bynum, J., Leland, N. E., Miller, S. C., Morden, N. E.,. Mor, V. (2013). Change in end-of-life care for Medicare beneficiaries: Site of death, place of care, and health care transitions in 2000, 2005, and 2009. Journal of the American Medical Association, 309(5), 470-477.
107. Thoits, P. A., & Virscup, L. K. (1997). Me's and we's: Forms and functions of social identities. In R. D. Ashmore & L. J. Jussim (Eds.), Self and identity: Fundamental issues (pp. 106-116). New York, NY: Oxford University Press.
108. Thompson, K. (2007). Liminality as a descriptor for the cancer experience. Illness, Crisis, & Loss, 15(4), 333-351.
109. Thun, M. J., DeLancey, J. O., Center, M. M., Jemal, A., & Ward, E. M. (2010). The global burden of cancer: Priorities for prevention. Carcinogenesis, 31(1), 100-110. doi:10.1093/carcin/bgp263
110. Tullis, J. A. (2010). Bring about benefit, forestall harm: What communication studies say about spirituality and cancer care. Asian Pacific Journal of Cancer Prevention, 11(MECC Suppl), 67-73.
111. Tulsky, J. (2002). Hope and hubris. Journal of Palliative Medicine, 5(3), 399-401. doi:10.1089/109662102320135225
112. Turner, V. (1967). The forest of symbols: Aspects of Ndembu ritual. Ithaca, NY: Cornell University Press.
113. Turner, V. (1969). The ritual process: Structure and anti-structure. Ithaca, NY: Cornell University Press.
114. van Duerzen, E. (1988). Existential counselling in practice. London: Sage.
115. van Gennep, A. (1909/2004). The rites of passage. New York, NY: Routledge.
116. Vernberg, D. (1998). Sociomedical models and the epistemology of risk: The shortcoming of medical decision-making research. Journal of Health & Social Policy, 9(4), 31-49.
117. Walter, T. (2002). Spirituality in palliative care: Opportunity or burden. Palliative Medicine, 16(2), 133-139.
118. Willet, J., & Deegan, M. J. (2001). Liminality and disability: Rites of passage and community in hypermodern society. Disability Studies Quarterly, 20(3), 137-152.
119. World Health Organization 2013 Cancer fact sheet http://www.who.int/mediacentre/factsheets/fs297/en/
120. Wright, A. A., & Katz, I. T. (2007). Letting go of the rope-Aggressive treatment, hospice care, and open access. The New England Journal of Medicine, 357(4), 324-327.
121. Wright, A. A., Zhang, B., Ray, A., Mack, J. W., Tric, E., Blaboni, T.,. Prigerson, H. G. (2008). Associations between end-of-life discussions, patient mental health, medical care near death, and caregiver bereavement adjustment. Journal of the American Medical Association, 300(14), 1665-1673. doi:10.1001/jama.300.14.1665
122. Wu, J., Joseph, S. O., & Muggia, F. M. (2012). Targeted therapy: Its status and promise in selected solid tumors part I. Oncology, 26(10), 936-943.
123. Yalom, I. D. (1980). Existential psychotherapy. New York, NY: Basic Books.
124. Yancik, R. (2005). Population aging and cancer: A cross-national concern. Cancer, 11(6), 437-441.